 |
| CytomX's Dan Bell (far right) and team. |
While researchers believe stem cell therapies can overcome diabetes, Alzheimer’s, spinal cord injuries and a host of other conditions, they’ve faced one big-time head scratcher: showing what those millions of cells actually do once they are in the body. Caleb Bell thinks his young company, Bell Biosystems, has a solution. The company, which recently moved from the Stanford University student-run incubator StartX to the Molecular Medicine Research Institute in Sunnyvale, is working on a way to magnetize cells so that they can be localized, tracked and, if necessary, killed when they go astray.
No comments:
Post a Comment